BioTelemetry, Inc. (BEAT): Price and Financial Metrics
GET POWR RATINGS... FREE!
BEAT Price/Volume Stats
| Current price | $2.18 | 52-week high | $6.74 |
| Prev. close | $2.26 | 52-week low | $1.12 |
| Day low | $2.02 | Volume | 198,800 |
| Day high | $2.28 | Avg. volume | 93,225 |
| 50-day MA | $2.22 | Dividend yield | N/A |
| 200-day MA | $3.19 | Market Cap | 56.46M |
BEAT Stock Price Chart Interactive Chart >
BioTelemetry, Inc. (BEAT) Company Bio
BioTelemetry Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services. The company is based in Malvern, Pennsylvania.
Latest BEAT News From Around the Web
Below are the latest news stories about HEARTBEAM INC that investors may wish to consider to help them evaluate BEAT as an investment opportunity.
HeartBeam Announces FDA Submission of HeartBeam AIMIGo™ VECG SystemSANTA CLARA, Calif., May 18, 2023--HeartBeam Announces FDA Submission of HeartBeam AIMIGo™ VECG System |
HeartBeam, Inc. (BEAT) Q1 2023 Earnings Call TranscriptHeartBeam, Inc. (BEAT) Q1 2023 Earnings Conference Call May 11, 2023 04.30 PM ET Company Participants Branislav Vajdic - Founder and Chief Executive Officer Rob Eno - President Richard Brounstein - Chief Financial Officer Conference Call Participants Jason Kolbert - Dawson James William Sutherland - The Benchmark Company Ben Haynor - Alliance Global Partners Presentation Operator Greetings and welcome to the HeartBeam First Quarter 2023 Financial Results Conference Call. At this time all participants are in listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. ... |
HeartBeam Reports First Quarter 2023 Financial ResultsSANTA CLARA, Calif., May 11, 2023--HeartBeam Reports First Quarter 2023 Financial Results |
HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial GuidanceSANTA CLARA, Calif., May 03, 2023--HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance |
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2022 Earnings Call TranscriptHeartBeam, Inc. (NASDAQ:BEAT) Q4 2022 Earnings Call Transcript March 17, 2023 Operator: Greetings. And welcome to the HeartBeam Fourth Quarter and Full-Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. Before we […] |
BEAT Price Returns
| 1-mo | -3.54% |
| 3-mo | -37.18% |
| 6-mo | -48.95% |
| 1-year | 42.48% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -55.33% |
| 2022 | 58.44% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Continue Researching BEAT
Want to do more research on Biotelemetry Inc's stock and its price? Try the links below:Biotelemetry Inc (BEAT) Stock Price | Nasdaq
Biotelemetry Inc (BEAT) Stock Quote, History and News - Yahoo Finance
Biotelemetry Inc (BEAT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...